This is an ambispective single-center cohort study of pediatric patients with portal hypertension and esophageal varices. The study was designed to evaluate the efficacy and safety of primary prophylaxis with endoscopic variceal ligation to prevent upper gastrointestinal bleeding compared to non-selected beta-blockers prophylaxis.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Number of patients that present the first episode of Upper Gastrointestinal Bleeding after the use of endoscopic variceal ligation as a prophylactic treatment (Efficacy)
Timeframe: From the moment the patients received the endoscpoic variceal ligation to the end of the follow-up (April 2019)
Number of patients that present adverse events related to the use of endoscopic variceal ligation as a prophylactic treatment (Safety)
Timeframe: From the moment the patients received the endoscpoic variceal ligation to the end of the follow-up (April 2019)